Publisher
Springer Berlin Heidelberg
Reference75 articles.
1. Attardi BJ, Hild SA, Reel JR et al (2000) CDB-4124: a potent antiprogestin with antiovulatory and postcoital antifertility activity [abstract 1293]. Proceedings of the 82nd Annual Meeting of the Endocrine Society; Toronto, Canada
2. Attardi BJ, Burgenson J, Hild SA et al (2002) CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914. Mol Cell Endocrinol 188:111–123
3. Baird DD, Dunson DB, Hill MC et al (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107
4. Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, Meligova AK, Alexis MN, Zoumpourlis V (2008) Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness. Fertil Steril 90:1878
5. Barbieri RL, Ryan KJ (1981) Danazol: endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol 141:453–463